Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual Meeting 2024 ELI-007 and ELI-008 […]
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company […]
BurgerFi to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
FORT LAUDERDALE, Fla., March 29, 2024 (GLOBE NEWSWIRE) — BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of […]
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target […]
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
— Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by year-end 2024 —— Exploring opportunities […]
Gentex Schedules First Quarter 2024 Earnings Release Date and Conference Call
ZEELAND, Mich., March 29, 2024 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected […]
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
Sioux Falls, SD , March 29, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results […]
Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to May 3, 2024
MIAMI, March 29, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose […]
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
Viactiv®Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately […]
Tri Pointe Homes, Inc. Announces First Quarter 2024 Earnings Release and Conference Call Date
INCLINE VILLAGE, Nev., March 29, 2024 (GLOBE NEWSWIRE) — Tri Pointe Homes, Inc. (NYSE: TPH) announced today that it will […]
